Related Experiment Video

Updated: Aug 22, 2026

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector
05:06

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector

Published on: February 2, 2021

Tumor induction by activated JNK occurs through deregulation of cellular growth

Ulrike Rennefahrt1, Bertram Illert, Axel Greiner

  • 1Institut für Medizinische Strahlenkunde und Zellforschung (MSZ), University of Würzburg, Würzburg, Germany.

Cancer Letters
|September 18, 2004
PubMed

Insights

Oncogenic Jun N-terminal kinases (JNKs) drive cellular transformation by promoting cell proliferation and tumor vascularization, but not cell survival. This study dissects the mechanisms of JNK signaling in cancer development.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncology

Background:

  • The Ras-Raf-MEK-ERK pathway is a known driver of cellular transformation.
  • Emerging evidence suggests a role for stress-activated protein kinases (SAPKs)/Jun N-terminal kinases (JNKs) in cellular transformation.

Purpose of the Study:

  • To investigate the specific mechanisms by which JNK signaling contributes to cellular transformation.
  • To analyze the transforming potential of an oncogenic JNK variant.

Main Methods:

  • Utilized a constitutively active SAPKbeta-MKK7 JNK variant.
  • Assessed tumor induction in nude mice.
  • Conducted in vitro studies and analyzed tumor material.

Main Results:

  • Oncogenic JNK (SAPKbeta-MKK7) acts as a weakly transforming oncogene in vitro.
  • Oncogenic JNK is sufficient for tumor induction in vivo.
  • JNK signaling primarily impacts cell proliferation and tumor vascularization, not cell survival.

Conclusions:

  • JNK signaling plays a significant role in cellular transformation and tumor development.
  • Targeting JNK pathways may offer therapeutic strategies for cancer by affecting proliferation and vascularization.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...